Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics.

Li JZ, Arnold KB, Lo J, Dugast AS, Plants J, Ribaudo HJ, Cesa K, Heisey A, Kuritzkes DR, Lauffenburger DA, Alter G, Landay A, Grinspoon S, Pereyra F.

Open Forum Infect Dis. 2015 Jan 13;2(1):ofu117. doi: 10.1093/ofid/ofu117. eCollection 2015 Jan.

2.

The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH): Design of a pharmacogenetic Resource for Type 2 Diabetes.

Walford GA, Colomo N, Todd JN, Billings LK, Fernandez M, Chamarthi B, Warner AS, Davis J, Littleton KR, Hernandez AM, Fanelli RR, Lanier A, Barbato C, Ackerman RJ, Khan SQ, Bui R, Garber L, Stolerman ES, Moore AF, Huang C, Kaur V, Harden M, Taylor A, Chen L, Manning AK, Huang P, Wexler D, McCarthy RM, Lo J, Thomas MK, Grant RW, Goldfine A, Hudson MS, Florez JC.

PLoS One. 2015 Mar 26;10(3):e0121553. doi: 10.1371/journal.pone.0121553. eCollection 2015.

3.

High-density lipoprotein-mediated cholesterol efflux capacity is improved by treatment with antiretroviral therapy in acute human immunodeficiency virus infection.

Lo J, Rosenberg ES, Fitzgerald ML, Bazner SB, Ihenachor EJ, Hawxhurst V, Borkowska AH, Wei J, Zimmerman CO, Burdo TH, Williams KC, Freeman MW, Grinspoon SK.

Open Forum Infect Dis. 2014 Dec 16;1(3):ofu108. doi: 10.1093/ofid/ofu108. eCollection 2014 Dec.

4.

Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine.

Srinivasa S, Fitch KV, Lo J, Kadar H, Knight R, Wong K, Abbara S, Gauguier D, Capeau J, Boccara F, Grinspoon SK.

AIDS. 2015 Feb 20;29(4):443-52. doi: 10.1097/QAD.0000000000000565.

PMID:
25565500
5.

2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without subclinical high-risk coronary plaque.

Zanni MV, Fitch KV, Feldpausch M, Han A, Lee H, Lu MT, Abbara S, Ribaudo H, Douglas PS, Hoffmann U, Lo J, Grinspoon SK.

AIDS. 2014 Sep 10;28(14):2061-70. doi: 10.1097/QAD.0000000000000360.

PMID:
25265074
6.

Soluble CD163 is associated with shortened telomere length in HIV-infected patients.

Srinivasa S, Fitch KV, Petrow E, Burdo TH, Williams KC, Lo J, Côté HC, Grinspoon SK.

J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):414-8. doi: 10.1097/QAI.0000000000000329.

PMID:
25197827
7.

Increased arterial inflammation relates to high-risk coronary plaque morphology in HIV-infected patients.

Tawakol A, Lo J, Zanni MV, Marmarelis E, Ihenachor EJ, MacNabb M, Wai B, Hoffmann U, Abbara S, Grinspoon S.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):164-71. doi: 10.1097/QAI.0000000000000138.

PMID:
24828267
8.

HDL redox activity is increased in HIV-infected men in association with macrophage activation and non-calcified coronary atherosclerotic plaque.

Zanni MV, Kelesidis T, Fitzgerald ML, Lo J, Abbara S, Wai B, Marmarelis E, Hernandez NJ, Yang OO, Currier JS, Grinspoon SK.

Antivir Ther. 2014;19(8):805-11. doi: 10.3851/IMP2756. Epub 2014 Feb 17.

PMID:
24535655
9.

Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women.

Fitch KV, Srinivasa S, Abbara S, Burdo TH, Williams KC, Eneh P, Lo J, Grinspoon SK.

J Infect Dis. 2013 Dec 1;208(11):1737-46. doi: 10.1093/infdis/jit508. Epub 2013 Sep 16.

10.

Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus.

Walford GA, Davis J, Warner AS, Ackerman RJ, Billings LK, Chamarthi B, Fanelli RR, Hernandez AM, Huang C, Khan SQ, Littleton KR, Lo J, McCarthy RM, Rhee EP, Deik A, Stolerman E, Taylor A, Hudson MS, Wang TJ, Altshuler D, Grant RW, Clish CB, Gerszten RE, Florez JC.

Metabolism. 2013 Dec;62(12):1772-8. doi: 10.1016/j.metabol.2013.07.003. Epub 2013 Aug 15.

11.

Cost-effectiveness analysis of coronary artery disease screening in HIV-infected men.

Nolte JE, Neumann T, Manne JM, Lo J, Neumann A, Mostardt S, Abbara S, Hoffmann U, Brady TJ, Wasem J, Grinspoon SK, Gazelle GS, Goehler A.

Eur J Prev Cardiol. 2013 Mar 28;21(8):972-979. [Epub ahead of print]

12.

Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men.

Zanni MV, Abbara S, Lo J, Wai B, Hark D, Marmarelis E, Grinspoon SK.

AIDS. 2013 May 15;27(8):1263-72. doi: 10.1097/QAD.0b013e32835eca9b.

13.

Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers.

Pereyra F, Lo J, Triant VA, Wei J, Buzon MJ, Fitch KV, Hwang J, Campbell JH, Burdo TH, Williams KC, Abbara S, Grinspoon SK.

AIDS. 2012 Nov 28;26(18):2409-12. doi: 10.1097/QAD.0b013e32835a9950.

14.

Receptor activator of nuclear factor-κB ligand (RANKL) and its relationship to coronary atherosclerosis in HIV patients.

Hwang JJ, Wei J, Abbara S, Grinspoon SK, Lo J.

J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):359-63. doi: 10.1097/QAI.0b013e31826a6c16.

15.

Arterial inflammation in patients with HIV.

Subramanian S, Tawakol A, Burdo TH, Abbara S, Wei J, Vijayakumar J, Corsini E, Abdelbaky A, Zanni MV, Hoffmann U, Williams KC, Lo J, Grinspoon SK.

JAMA. 2012 Jul 25;308(4):379-86. doi: 10.1001/jama.2012.6698.

16.

The biology of atherosclerosis: general paradigms and distinct pathogenic mechanisms among HIV-infected patients.

Lo J, Plutzky J.

J Infect Dis. 2012 Jun;205 Suppl 3:S368-74. doi: 10.1093/infdis/jis201. Review.

17.

Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.

Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, Preffer F, Rosenberg ES, Williams KC, Grinspoon S.

J Infect Dis. 2011 Oct 15;204(8):1227-36. doi: 10.1093/infdis/jir520.

18.

Dyslipidemia and lipid management in HIV-infected patients.

Lo J.

Curr Opin Endocrinol Diabetes Obes. 2011 Apr;18(2):144-7. doi: 10.1097/MED.0b013e328344556e. Review.

19.

Increased coronary artery calcium score and noncalcified plaque among HIV-infected men: relationship to metabolic syndrome and cardiac risk parameters.

Fitch KV, Lo J, Abbara S, Ghoshhajra B, Shturman L, Soni A, Sacks R, Wei J, Grinspoon S.

J Acquir Immune Defic Syndr. 2010 Dec;55(4):495-9. doi: 10.1097/QAI.0b013e3181edab0b.

20.

Effects of low-dose growth hormone withdrawal in patients with HIV.

Lo J, You SM, Liebau J, Lee H, Grinspoon S.

JAMA. 2010 Jul 21;304(3):272-4. doi: 10.1001/jama.2010.989. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk